Antibiotic Resistances of Clostridium difficile
- PMID: 29383668
- DOI: 10.1007/978-3-319-72799-8_9
Antibiotic Resistances of Clostridium difficile
Abstract
The rapid evolution of antibiotic resistance in Clostridium difficile and the consequent effects on prevention and treatment of C. difficile infections (CDIs) are matter of concern for public health. Antibiotic resistance plays an important role in driving C. difficile epidemiology. Emergence of new types is often associated with the emergence of new resistances and most of epidemic C. difficile clinical isolates is currently resistant to multiple antibiotics. In particular, it is to worth to note the recent identification of strains with reduced susceptibility to the first-line antibiotics for CDI treatment and/or for relapsing infections. Antibiotic resistance in C. difficile has a multifactorial nature. Acquisition of genetic elements and alterations of the antibiotic target sites, as well as other factors, such as variations in the metabolic pathways and biofilm production, contribute to the survival of this pathogen in the presence of antibiotics. Different transfer mechanisms facilitate the spread of mobile elements among C. difficile strains and between C. difficile and other species. Furthermore, recent data indicate that both genetic elements and alterations in the antibiotic targets can be maintained in C. difficile regardless of the burden imposed on fitness, and therefore resistances may persist in C. difficile population in absence of antibiotic selective pressure.
Keywords: Antibiotic susceptibility methods; C. difficile; Mechanisms of resistance; Multi-drug resistance (MDR).
Similar articles
-
Antibiotic Resistances of Clostridioides difficile.Adv Exp Med Biol. 2024;1435:169-198. doi: 10.1007/978-3-031-42108-2_9. Adv Exp Med Biol. 2024. PMID: 38175476
-
Recent advances in the understanding of antibiotic resistance in Clostridium difficile infection.Ther Adv Infect Dis. 2016 Feb;3(1):23-42. doi: 10.1177/2049936115622891. Ther Adv Infect Dis. 2016. PMID: 26862400 Free PMC article. Review.
-
Clostridium difficile Biofilm.Adv Exp Med Biol. 2018;1050:97-115. doi: 10.1007/978-3-319-72799-8_7. Adv Exp Med Biol. 2018. PMID: 29383666 Review.
-
Update on Antimicrobial Resistance in Clostridium difficile: Resistance Mechanisms and Antimicrobial Susceptibility Testing.J Clin Microbiol. 2017 Jul;55(7):1998-2008. doi: 10.1128/JCM.02250-16. Epub 2017 Apr 12. J Clin Microbiol. 2017. PMID: 28404671 Free PMC article. Review.
-
Clostridium difficile Infections: A Global Overview of Drug Sensitivity and Resistance Mechanisms.Biomed Res Int. 2018 Feb 21;2018:8414257. doi: 10.1155/2018/8414257. eCollection 2018. Biomed Res Int. 2018. PMID: 29682562 Free PMC article. Review.
Cited by
-
Antibiotic Resistance in the Elderly: Mechanisms, Risk Factors, and Solutions.Microorganisms. 2024 Sep 30;12(10):1978. doi: 10.3390/microorganisms12101978. Microorganisms. 2024. PMID: 39458286 Free PMC article. Review.
-
Clostridioides difficile in Calves in Central Italy: Prevalence, Molecular Typing, Antimicrobial Susceptibility and Association with Antibiotic Administration.Animals (Basel). 2021 Feb 16;11(2):515. doi: 10.3390/ani11020515. Animals (Basel). 2021. PMID: 33669325 Free PMC article.
-
Clostridioides difficile infection (CDI) during the COVID-19 pandemic.Anaerobe. 2022 Apr;74:102518. doi: 10.1016/j.anaerobe.2022.102518. Epub 2022 Jan 19. Anaerobe. 2022. PMID: 35063599 Free PMC article. Review.
-
Antibiotic Resistance Profile of RT 027/176 Versus Other Clostridioides difficile Isolates in Silesia, Southern Poland.Pathogens. 2022 Aug 22;11(8):949. doi: 10.3390/pathogens11080949. Pathogens. 2022. PMID: 36015069 Free PMC article.
-
Defining the phylogenetics and resistome of the major Clostridioides difficile ribotypes circulating in Australia.Microb Genom. 2024 May;10(5):001232. doi: 10.1099/mgen.0.001232. Microb Genom. 2024. PMID: 38717815 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical